Mutual Fund Details

Mirae Asset Healthcare Fund Direct-IDCW Reinvestment

Equity Pharma

NAV

₹23.6370

as on 19 Apr 2024, 11:15 PM

₹-0.1270(0.53%)

Last Change

Schemes Managed By

Vrijesh Kasera

Fund Manager

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,52,164

₹1,59,263

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹59,263

Profit (absolute return)

59.26%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

5.53%

In the last 6 months

19.55%

In the last 1 year

47.73%

In the last 3 years

59.26%

In the last 5 years

207.56%

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

Mirae Asset Healthcare Fund Direct-IDCW Reinvestment

as of 31 Mar 2024, 05:30 AM

₹2,235.15 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit load of 1% if redeemed within 1 year.

0.54%

Expense Ratio

Plan

Dividend

0.32%

Cash Holding

Benchmark

S&P BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

S&P BSE Healthcare Total Return Index

Exit Load

Exit load of 1% if redeemed within 1 year.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Sector

Healthcare

96.44%

₹2,155.64 Cr

Chemicals

1.78%

₹39.82 Cr

Financial

1.35%

₹30.19 Cr

Others

0.42%

₹9.39 Cr

Sectors Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Sector

Healthcare

96.44%

₹2,155.64 Cr

Chemicals

1.78%

₹39.82 Cr

Financial

1.35%

₹30.19 Cr

Others

0.42%

₹9.39 Cr

Companies Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

14.92%

₹333.48 Cr

Cipla Ltd.

9.62%

₹215.02 Cr

Aurobindo Pharma Ltd.

8.25%

₹184.40 Cr

Dr. Reddy's Laboratories Ltd.

7.17%

₹160.26 Cr

Apollo Hospitals Enterprise Ltd.

6.34%

₹141.71 Cr

Others

53.70%

₹1,200.28 Cr

View All

Companies Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

14.92%

₹333.48 Cr

Cipla Ltd.

9.62%

₹215.02 Cr

Aurobindo Pharma Ltd.

8.25%

₹184.40 Cr

Dr. Reddy's Laboratories Ltd.

7.17%

₹160.26 Cr

Apollo Hospitals Enterprise Ltd.

6.34%

₹141.71 Cr

Others

53.70%

₹1,200.28 Cr

View All

Funds in this Category

This fund's returns:

16.73%

Return Duration

3 Years

SBI Healthcare Opportunities Fund Direct Plan-Growth

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

Tata India Pharma & HealthCare Fund Direct-Growth

About Mirae Asset Healthcare Fund Direct-IDCW Reinvestment

Mirae Asset Healthcare Fund Direct-IDCW Reinvestment is a Equity mutual fund scheme from Mirae Asset Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Vrijesh Kasera. It has an AUM of ₹2,235.15 Crores and the latest NAV decalared is ₹23.637 as on 19 Apr 2024 at 11:36 pm.

Mirae Asset Healthcare Fund Direct-IDCW Reinvestment scheme return performance in last 1 year is 47.73%, in last 3 years is 59.26% and 259.94% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.